"Molding" immunity-modulation of mucosal and systemic immunity by the intestinal mycobiome in health and disease

Mucosal Immunol. 2022 Apr;15(4):573-583. doi: 10.1038/s41385-022-00515-w. Epub 2022 Apr 26.

Abstract

Fungi are important yet understudied contributors to the microbial communities of the gastrointestinal tract. Starting at birth, the intestinal mycobiome undergoes a period of dynamic maturation under the influence of microbial, host, and extrinsic influences, with profound functional implications for immune development in early life, and regulation of immune homeostasis throughout life. Candida albicans serves as a model organism for understanding the cross-talk between fungal colonization dynamics and immunity, and exemplifies unique mechanisms of fungal-immune interactions, including fungal dimorphism, though our understanding of other intestinal fungi is growing. Given the prominent role of the gut mycobiome in promoting immune homeostasis, emerging evidence points to fungal dysbiosis as an influential contributor to immune dysregulation in a variety of inflammatory and infectious diseases. Here we review current knowledge on the factors that govern host-fungi interactions in the intestinal tract and immunological outcomes in both mucosal and systemic compartments.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Candida albicans
  • Dysbiosis / microbiology
  • Fungi / physiology
  • Gastrointestinal Tract / microbiology
  • Humans
  • Immunity, Mucosal
  • Infant, Newborn
  • Microbiota*
  • Mycobiome* / physiology

Grants and funding